News & Events

GAiT Director Annelise Bennaceur Griscelli speaking about iPSC manufacture https://youtu.be/ktjX-ADEz-8

GAiT will speak at this virtual regenerative medicine symposium held by the Tissue Cure Alliance Finland on the 20th January 2022 http://tissuecure.fi

Happy Holidays to all GAiT members and collaborators. We are excited to continue working with you in the new year.

GAiT and @CiRA_F_J will be launching a call for expressions of interest for the 2nd iPSC Quality Assessment Round next week. The Round will focus on Characterization by Flow Cytometry. The call will stay open until March 2022.

The iPSC Quality Assessment Round Manuscript has been submitted for peer review.

GAiT is hosting another Industry Liaison Meeting today where the agenda and format of the iPSC Industry Workshop @Phacilitate Advanced Therapies week will be discussed and decided. The meeting is chaired by GAiT Director @MichaelMay5 and @CIRM_F's Noriko Shimasaki

Thanks to all iPSC Quality Assessment Round authors for your final edits. We will now review, amend and move to submit the manuscript for peer review.

A scheduling poll has been sent out to GAiT Industrial Liaison Committee Members to schedule November's meeting. Please respond by 5th November. Thank you.

Save the date: GAiT iPSC Industry Workshop Tuesday 25th January 2021 9.30am - 2.30pm @Phacilitate Advanced Therapies Week.

The deadline for comments/questions/suggested edits for the Quality Assessment Round Manuscript is this Sunday, 31st October 2021. If authors cannot access the manuscript, please contact stephen.sullivan@gait.global directly.

Looking forward to meeting GAiT members at the annual @NYSCF meeting http://www.nyscf.org/events

The iPSC Quality Assessment Round Data Manuscript has been sent to all Authors for final review. Please check your inboxes. We shall submit the manuscript after responding to final questions and comments.

The iPSC Quality Assessment Round Manuscript is to be circulated to all authors tomorrow for final review & edit before submission. Authors will have two weeks to review. Well done to all Organizers and Participants for getting this far, especially with all the COVID disruption.

Did you know? GAiT's Industry Liaison Committee is co-chaired by @CiRA_F_J pediatric oncologist Dr. Noriko Shimasaki and @CCRM_ca President/CEO and GAiT Director Dr @MichaelMay5. The Committee focuses on accelerating iPSC therapies to the clinic.

GAiT members are hoping to see each other in person at Phacilitate Advanced Therapies Week in Miami. Register at https://www.advancedtherapiesweek.com/welcome